GEMINI THERAPEUTICS Trademark

Trademark Overview

On Thursday, June 30, 2016, a trademark application was filed for GEMINI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GEMINI THERAPEUTICS trademark a serial number of 87089097. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2018. This trademark is owned by Gemini Therapeutics, Inc.. The GEMINI THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the fields of biotechnology, pharmaceuticals, and new therapeutics all relating to ophthalmology
gemini therapeutics

General Information

Serial Number87089097
Word MarkGEMINI THERAPEUTICS
Filing DateThursday, June 30, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 29, 2016

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of three concentric circles with the words "GEMINI THERAPEUTICS" below.
Goods and ServicesResearch and development in the fields of biotechnology, pharmaceuticals, and new therapeutics all relating to ophthalmology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 5, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGemini Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameGemini Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2017EXTENSION 1 GRANTED
Thursday, June 22, 2017EXTENSION 1 FILED
Thursday, June 22, 2017TEAS EXTENSION RECEIVED
Tuesday, January 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, October 23, 2016ASSIGNED TO LIE
Tuesday, October 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 11, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, October 11, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 11, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, October 11, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 11, 2016ASSIGNED TO EXAMINER
Wednesday, July 6, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics gemini relating ophthalmology pharmaceuticals biotechnology development fields research